Jubilant Pharmova Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 60,591.7 million compared to INR 59,638.8 million a year ago. Revenue was INR 61,414.5 million compared to INR 61,161.8 million a year ago. Net income was INR 4,139.4 million compared to INR 8,358.7 million a year ago. Basic earnings per share from continuing operations was INR 26 compared to INR 36.05 a year ago. Diluted earnings per share from continuing operations was INR 26 compared to INR 36.05 a year ago. Basic earnings per share was INR 26 compared to INR 52.48 a year ago. Diluted earnings per share was INR 26 compared to INR 52.48 a year ago.